`Case 1:22-cv-00252-MSG Document 211-17 Filed 02/02/24 Page 1 of 2 PagelD #: 14495
`
`EXHIBIT M
`EXHIBIT M
`
`
`
`Case 1:22-cv-00252-MSG Document 211-17 Filed 02/02/24 Page 2 of 2 PageID #: 14496
`
`Date:
`
`Subject:
`
`Monday, August 30 2021 05:29 PM
`Notice of Allowance Received 8/30/2 1; Issue Fee Payment filed 8/30/21 - U.S. Application
`No. 17/227,802 -KTS Ref. 104290-007791US-1243808
`Lane, Sharleen
`
`From:
`To:
`
`CC:
`
`Attachments:
`
`
`'Hao, Joe (jhao@kilpatricktownsend.com)' <jhao akilpatricktownsend.com >;
`
`image001.jpg; 2021-08-30 FWR ISSUEFEE 104290-007791 US- 1243808.PDF; 2021-08-30
`Notice of Allowance - 007791 US.PDF
`U.S. Patent Application No. 17/227,802 (Track 1)
`Re:
`Filing Date: April 12, 2021
`Title: NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
`Applicant: Arbutus Biopharma Corporation
`First Inventor: Ed Yaworski
`KTS Ref.: 104290-007791US-1243808
`
`Dear
`
`:
`
`we paid the Issue Fee today to the U.S. Patent Office in response to the Notice of
`Redacted - Privileged
`dated August30, 2021. Attached foryour records is a copy of the Issue Fee Transmittal as filed and payment
`- Redacted - Privileged _____
`
`_.
`
`-.
`
`Allowance
`
`receipt.
`
`Redacted - Privileged
`
`we also attach a copy of the Notice of Allowance dated August 30, 2021.
`
`Please let us know if you have any questions.
`
`Very truly yours,
`
`K
`
`"K
`
`Sharleen Lane
`PaL.,... Specialist
`Kilpatrick Townsend & Stockton LLP
`Suite 600 2175 North California Boulevard I Walnut Creek, CA 94596
`office 925 472 5009 1 fax 925 407 8366
`slane@kilpatricktownsend.com I www.kilpatricktownsend.com I vCard
`
`CONFIDENTIAL
`
`GENV-00031179
`
`